Wednesday, July 8, 2026

Drug profile · INN

omega-3acid ethyl esters

omega-3acid ethyl esters (OMACOR) is a unknown. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — omega-3acid ethyl esters
US status
approved
Class
Route
ORAL
Patents
0
Programs
2
Data quality
0.84

Quick answer

omega-3acid ethyl esters (OMACOR) is a unknown. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN omega-3acid ethyl esters
Brand OMACOR
Mechanism Unknown
Route ORAL
Formulation CAPSULE

Mechanism of action

Unknown

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. MUCODRILL for Ultra High Risk of psychosis an… Approved · PARItec · Ultra High Risk of psychosis and first episode psychosis
  2. OMACOR Approved · United Therapeutics Europe · Non-Alcoholic Fatty Liver Disease

Frequently asked questions

What is omega-3acid ethyl esters?

omega-3acid ethyl esters (OMACOR) is a unknown. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for omega-3acid ethyl esters?

OMACOR is a marketed brand name for omega-3acid ethyl esters. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of omega-3acid ethyl esters?

omega-3acid ethyl esters has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.